BIOTECH GROWTH N V

Average Profitability
<0.0001%
Insider Buys Quantity
12
Insider Buys Sum
$27.2M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of BIOTECH GROWTH N V

According to the SEC Form 4 filings, BIOTECH GROWTH N V, being in a position of

  1. 10 percent owner at Black Diamond Therapeutics, Inc.,
    оver the last 12 months, has bought 400000 shares for $934,080, and sold 0 shares,
    over all time since 2022-10-19, has bought 3823726 shares for $16.76M, and sold 0 shares.

The largest purchase of all time was on 2023-06-27 and amounted to 1740000 shares of Black Diamond Therapeutics, Inc. for $9.56M.

Biography of BIOTECH GROWTH N V

No biography is available at this moment.

2023-10-17PurchaseBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
400,000
0.7707%
$2.34$934,080+100.85%
2023-06-30PurchaseBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
1M
2.7138%
$5.00$5M-28.71%
2023-06-27PurchaseBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
1.74M
4.2378%
$5.49$9.56M-41.59%
2022-10-31PurchaseBlack Diamond Therapeutics, Inc.
BDTX
director
99,801
0.268%
$2.25$224,912-6.28%
2022-10-28PurchaseBlack Diamond Therapeutics, Inc.
BDTX
director
172,974
0.4696%
$2.18$376,962-1.81%
2022-10-27PurchaseBlack Diamond Therapeutics, Inc.
BDTX
director
191,678
0.5124%
$1.87$359,224+12.69%
2022-10-27PurchaseESSA Pharma Inc.
EPIX
director
500,000
1.1742%
$4.50$2.25M-32.41%
2022-10-26PurchaseESSA Pharma Inc.
EPIX
director
1.5M
2.8096%
$3.98$5.97M-39%
2022-10-21PurchaseBlack Diamond Therapeutics, Inc.
BDTX
director
87,850
0.2313%
$1.51$132,750+37.97%
2022-10-20PurchaseBlack Diamond Therapeutics, Inc.
BDTX
director
53,734
0.144%
$1.42$76,345+48.97%
2022-10-19PurchaseBlack Diamond Therapeutics, Inc.
BDTX
director
77,689
0.2096%
$1.32$102,775+61.48%
2021-08-18PurchaseESSA Pharma Inc.
EPIX
10 percent owner
250,000
0.6078%
$8.88$2.22M-9.55%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.